Episode Details
Back to Episodes
Fampridine Finally Available in England | UK News
Description
NHS England is finally rolling out fampridine, the first MS drug designed to boost walking ability—potentially helping 5,000 people annually. After years of being deemed too costly, the drug’s value is now recognized, offering hope to patients like Aysen Slack, who previously couldn’t afford it. A one-month trial determines eligibility; clinical trials show 40% of users saw meaningful mobility gains. Not a cure, but a lifeline—restoring independence, freedom, and the simple joy of movement.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/ca97257f8878bd66